###begin article-title 0
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
A Dinucleotide Deletion in CD24 Confers Protection against Autoimmune Diseases
###end article-title 0
###begin p 1
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 825 828 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 825 828 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 839 843 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1006 1007 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1297 1300 1285 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 1297 1300 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 1366 1367 1354 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1519 1520 1507 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1703 1707 1691 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1798 1802 1786 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 325 330 <span type="species:ncbi:9606">human</span>
It is generally believed that susceptibility to both organ-specific and systemic autoimmune diseases is under polygenic control. Although multiple genes have been implicated in each type of autoimmune disease, few are known to have a significant impact on both. Here, we investigated the significance of polymorphisms in the human gene CD24 and the susceptibility to multiple sclerosis (MS) and systemic lupus erythematosus (SLE). We used cases/control studies to determine the association between CD24 polymorphism and the risk of MS and SLE. In addition, we also considered transmission disequilibrium tests using family data from two cohorts consisting of a total of 150 pedigrees of MS families and 187 pedigrees of SLE families. Our analyses revealed that a dinucleotide deletion at position 1527approximately1528 (P1527del) from the CD24 mRNA translation start site is associated with a significantly reduced risk (odds ratio = 0.54 with 95% confidence interval = 0.34-0.82) and delayed progression (p = 0.0188) of MS. Among the SLE cohort, we found a similar reduction of risk with the same polymorphism (odds ratio = 0.38, confidence interval = 0.22-0.62). More importantly, using 150 pedigrees of MS families from two independent cohorts and the TRANSMIT software, we found that the P1527del allele was preferentially transmitted to unaffected individuals (p = 0.002). Likewise, an analysis of 187 SLE families revealed the dinucleotide-deleted allele was preferentially transmitted to unaffected individuals (p = 0.002). The mRNA levels for the dinucleotide-deletion allele were 2.5-fold less than that of the wild-type allele. The dinucleotide deletion significantly reduced the stability of CD24 mRNA. Our results demonstrate that a destabilizing dinucleotide deletion in the 3' UTR of CD24 mRNA conveys significant protection against both MS and SLE.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 454 458 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 846 850 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1099 1103 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 937 945 <span type="species:ncbi:9606">patients</span>
When an individual's immune system attacks self tissues or organs, he/she develops autoimmune diseases. Although it is well established that multiple genes control susceptibility to autoimmune diseases, most of the genes remain unidentified. In addition, although different autoimmune diseases have a common immunological basis, a very small number of genes have been identified that affect multiple autoimmune diseases. Here we show that a variation in CD24 is a likely genetic factor for the risk and progression of two types of autoimmune diseases, including multiple sclerosis (MS), an organ-specific autoimmune disease affecting the central nervous system, and systemic lupus erythematosus, a systemic autoimmune disease. Our data indicated that if an individual's CD24 gene has a specific two-nucleotide deletion in the noncoding region of CD24 mRNA, his/her risk of developing MS or SLE is reduced by 2- to 3-fold. As a group, MS patients with the two-nucleotide deletion will likely have a slower disease progression. Biochemical analysis indicated that the deletion leads to rapid decay of CD24 mRNA, which should result in reduced synthesis of the CD24 protein. Our data may be useful for the treatment and diagnosis of autoimmune diseases.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b001">1</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b006">6</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b002">2</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b004">4</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b007">7</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b001">1</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b002">2</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b008">8</xref>
###xml 835 838 835 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 848 851 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR2</italic>
###xml 862 898 862 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(HLA-DRB1*1501-DQA1*0102-DQB1*0602),</italic>
###xml 954 955 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b009">9</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b011">11</xref>
Multiple sclerosis (MS) is a chronic, inflammatory neurodegenerative disease of the central nervous system of unknown etiology. There is evidence to support the hypothesis that MS is an autoimmune process modulated by both genetic and environmental factors [1-6]. An increased risk of MS among MS relatives has been found in numerous prospective epidemiological studies [2,4,7]. Twin studies from different populations consistently indicate that a monozygotic twin has a 5- to 6-fold higher risk of MS than a dizygotic twin [1,2,8]. Collectively, these findings would implicate that, at least in part, the risk for developing this disorder and possibly its progression are mediated by multiple genetic factors. Several whole-genome screens were performed in MS affected families. These studies confirmed the association of MS with the HLA class II DR2 haplotype (HLA-DRB1*1501-DQA1*0102-DQB1*0602), but failed to confirm other major putative loci in MS [9-11].
###end p 6
###begin p 7
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b012">12</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b017">17</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b018">18</xref>
Systemic lupus erythematosus (SLE) is a classic systemic autoimmune disease with diverse clinical symptoms, including fatigue, joint pain and swelling, skin rashes, and chest pain. Severe SLE complications include nephritis, central nervous system vasculitis, pulmonary hypertension, interstitial lung disease, and stroke. Whole-genome scans have revealed multiple chromosomal regions [12-17]. However, the identity of most susceptibility genes are unknown [18].
###end p 7
###begin p 8
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b019">19</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b020">20</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b021">21</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b022">22</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b023">23</xref>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24,</italic>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b010">10</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b024">24</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b024">24</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b025">25</xref>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
CD24 is a glycosylphosphatidylinositol-anchored cell surface protein with expression in a variety of cell types that can participate in the pathogenesis of MS and SLE, including activated T cells [19,20], B cells [21], macrophages [22], and dendritic cells [23]. CD24, as a candidate locus [10], was shown to be essential for the induction of experimental autoimmune encephalomyelitis (EAE) in mice [24]. Interestingly, CD24 controls a checkpoint of EAE pathogenesis after the autoreactive T cells are produced [24]. Recently, we showed that CD24 is essential for local clonal expansion and persistence of T cells after their migration into the central nervous system and that expression of CD24 on either hematopoietic cells or nonhematopoietic antigen-presenting cells in the recipient is sufficient to confer susceptibility to EAE [25]. These findings suggest that CD24 is essential for susceptibility to EAE.
###end p 8
###begin p 9
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b026">26</xref>
###xml 337 339 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</sup>
###xml 337 339 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TT</sup></italic>
###xml 397 399 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT</sup>
###xml 397 399 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>CT</sup></italic>
###xml 407 409 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</sup>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>CC</sup></italic>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b027">27</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b028">28</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b029">29</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b030">30</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CD24 (CD24) mRNA has a 0.24-kb ORF and a 1.8-kb 3' UTR. A CT single nucleotide polymorphism (SNP) at position 170 from the CD24 translation start site (P170) in the CD24 putative cleavage site for the glycosylphosphatidylinositol anchor (-1 position) [26] results in the nonconservative replacement of alanine with valine. The P170TT genotype expressed higher cell-surface CD24 than the P170CT or P170CC genotypes, which had an increased risk and more rapid progression of MS [27]. Thus, the CD24 SNP may influence MS pathogenesis by affecting the expression of CD24. The potential contribution of CD24 to SLE has not been studied. However, since CD24 has emerged as a major checkpoint of homeostatic proliferation in lymphopenic hosts [28,29], and since leucopenia is a defining feature of SLE [30], it would be of great interest to evaluate whether CD24 polymorphism may affect susceptibility to SLE.
###end p 9
###begin p 10
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cd24</italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b031">31</xref>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cd24</italic>
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cd24</italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b031">31</xref>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 800 804 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
###xml 677 682 <span type="species:ncbi:9606">human</span>
Interestingly, the long 3' UTR of mouse Cd24 mRNA plays an important role in controlling CD24 expression [31]. Two cis elements of mouse Cd24 mRNA, a negative and a positive cis element, regulate the stability of mouse Cd24 mRNA expression and determine cell-surface CD24 expression [31]. Our sequencing analysis of the 3' UTR of CD24 revealed four polymorphisms in the Ohio population. Considering the importance of CD24 in the development and progression of MS, we investigated the association of the CD24 polymorphisms at the 3' UTR with the susceptibility to both organ-specific and systemic autoimmune diseases. Our study revealed a dinucleotide deletion in the 3' UTR of human CD24 that confers significant protection against the risk and progression of MS and the risk of SLE by destabilizing CD24 mRNA.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
CD24 Chromosomal Location and Polymorphisms in the 3' UTR
###end title 12
###begin p 13
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b032">32</xref>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b032">32</xref>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 435 444 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-sg001">Figure S1</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1046 1055 1046 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-sg002">Figure S2</xref>
###xml 1354 1358 1354 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b032">32</xref>
###xml 1397 1406 1397 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-sg002">Figure S2</xref>
###xml 1546 1550 1546 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
CD24 has been identified as an autosomal gene located in Chromosome 6q21 [32], with intronless pseudogenes in Chromosomes 1, 15, and Y. In addition to a lack of introns, it has been reported that Chromosome Y DNA sequence differs from CD24 cDNA at 23 positions, with two changes in the coding regions and the remaining ones scattered through the 1.6-kb cDNA region [32]. The CD24 gene sequence, as assembled by Celera, is presented in Figure S1. However, a recent update in the National Center for Biotechnology Information (NCBI) database placed CD24 on Chromosome Y with partial intron 1 sequence and exon 2 identical to the cDNA except for eight changes in the region corresponding to the 3' end of the cDNA. We used PCR primers antisense to a portion of the intronic sequence and the 3' end of the CD24 mRNA to amplify from genomic DNA, using as templates genomic DNA from eight unrelated normal individuals (four males and four females). Since the primers would amplify both the Chromosome 6 sequence and the putative Chromosome Y sequence (Figure S2), we sequenced five clones from each of the eight individuals in order to determine which annotation is correct. We found that none of the 40 sequences matched the putative Chromosome Y sequence, regardless of the sex of the donor, and all sequences matched the intron 1 and exon 2 sequence of the CD24 gene as located on Chromosome 6 [32] (Figure S2). These results indicated that the putative Chromosome Y sequence is likely incorrect and that the PCR primer pair amplifies the autosomal CD24 gene.
###end p 13
###begin p 14
###xml 188 196 188 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g001">Figure 1</xref>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b032">32</xref>
###xml 710 718 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-st001">Table S1</xref>
###xml 846 854 846 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-st001">Table S1</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b033">33</xref>
Analysis of five clones from each of the eight individuals also revealed four SNPs, three of which were reported in the NCBI database (P1056 A/G, P1527 TG/del, and P1626 A/G). As shown in Figure 1, following an anchored PCR designed to eliminate the contribution of intronless CD24 pseudogenes [32], these three polymorphic sites could be identified by restriction enzyme digestion of individual PCR products. The accuracy of the PCR-restriction length fragment polymorphism (RFLP)was confirmed by sequencing the PCR products from 32 individuals. The PCR-RFLP analysis was therefore adopted for genotyping. The genotype distributions of these polymorphisms did not deviate from the Hardy-Weinberg equilibrium (Table S1). Moreover, the genotype distributions are essentially the same among males and females among the large set of samples tested (Table S1). We also used Merlin software () to detect potential genotyping errors [33]. No Mendelian inconsistency and obligatory double recombination were found. Taken together, these data ruled out the possibility that the Chromosome Y locus contributes to the data presented in this study and confirmed the accuracy of the genotypes presented.
###end p 14
###begin title 15
Case-Control Studies on 3'-UTR Polymorphisms and the Risk of MS
###end title 15
###begin p 16
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 197 204 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t001">Table 1</xref>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t002">Table 2</xref>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 113 125 <span type="species:ncbi:9606">participants</span>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
We examined the association of the CD24 polymorphisms in the 3' UTR with MS using DNA from independent Caucasian participants with MS and race-, age- and gender-matched controls from Central Ohio (Table 1). A summary of the CD24 allele and genotype analyses of the MS patients compared with controls is shown in Table 2. A significant difference in the allelic frequencies between the MS patients and the controls was found for P1527 (p = 0.006), but not for P1056 or P1626.
###end p 16
###begin p 17
###xml 104 110 104 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 119 126 119 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del/del</sup>
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del/del</sup></italic>
###xml 160 165 160 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/TG</sup>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/TG</sup></italic>
###xml 77 89 <span type="species:ncbi:9606">participants</span>
Remarkably, an approximately 2-fold decrease in the risk for MS was found in participants with the P1527TG/del or P1527del/del genotypes compared with the P1527TG/TG genotype. These data suggest that the dinucleotide deletion may confer protection against MS risk.
###end p 17
###begin title 18
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Family-Based Tests for the Association between CD24 Polymorphisms and MS
###end title 18
###begin p 19
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 630 638 630 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-st002">Table S2</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b034">34</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b035">35</xref>
###xml 707 708 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Since the above case-control results could potentially be due to population admixture, even though we have restricted the analysis to only the Caucasian samples, we also considered transmission disequilibrium tests using family data, as such a test is still valid under population admixture. We used a total of 150 pedigrees, including 49 pedigrees from the Multiple Sclerosis Genetics Group (MSGG) (with 63 informative nuclear families) and 101 from central Ohio (with 93 informative nuclear families), to determine whether the CD24 polymorphisms are associated with MS risk. The family compositions of both cohorts are shown in Table S2. A strong association in P1527 was found using TRANSMIT () [34,35] (p = 0.002). No significant association was observed with other SNPs.
###end p 19
###begin p 20
###xml 153 161 153 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g002">Figure 2</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g002">2</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b027">27</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b036">36</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b037">37</xref>
###xml 723 734 <span type="species:ncbi:9606">participant</span>
Linkage disequilibrium (LD) analysis of the four SNPs using the 150 MS and 187 SLE family samples revealed a surprisingly low LD between P170 and P1527 (Figure 2A and 2B). Considering the short distance between the SNPs, it is possible that a recombination hotspot may exist in the CD24 gene. These results, together with the fact that P1056 and P1626 are not significantly associated with MS susceptibility, suggest that P170 and P1527 are independently associated with MS risk. Such an interpretation is plausible since the allele frequencies of the SNPs are not very similar, which diminishes the power of detecting association even for a nearby SNP in high LD with the causal SNP. The significance of the origin of the participant in the association of P170 has been highlighted in recent studies by us and others [27,36,37].
###end p 20
###begin title 21
The Association of SNPs P1527 and P1626 with the Progression of MS
###end title 21
###begin p 22
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 382 389 <span type="species:ncbi:9606">patient</span>
###xml 547 555 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">patients</span>
MS disease severity is usually measured according to the expanded disability status scale (EDSS). MS patients who have lost the ability to walk without aid have reached EDSS 6.0. For the majority of the patients, their EDSS 6.0 status was based on a follow-up visit to our center. A few of the cases were based on case history. Because this is one of the most traumatic events in a patient's life, most can recall accurately the time when their disease reached EDSS 6.0. We then tested whether the CD24 genotype affected the time span it took the patients to reach EDSS 6.0 from the day of the first symptom of MS. Clinical data from 275 independent Caucasian MS patients in the Ohio cohorts, but not those from the MSGG, were available for the survival analysis.
###end p 22
###begin p 23
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g003">Figure 3</xref>
###xml 184 190 184 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 199 206 199 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del/del</sup>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del/del</sup></italic>
###xml 288 293 288 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/TG</sup>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/TG</sup></italic>
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 357 359 357 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>AA</sup></italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
The Kaplan-Meier curves provide estimates of the distribution of the time it took to reach EDSS 6.0 for patients with different genotypes. As shown in Figure 3, patients with the P1527TG/del or P1527del/del genotype had a more delayed disease progression pattern than those with the P1527TG/TG genotype (p = 0.0188). In addition, the patients with the P1626AA genotype also showed faster progression (p = 0.0105). No significant result was found in the patients with the P1056 genotype.
###end p 23
###begin title 24
Case-Control Studies on the 3' UTR Polymorphism and the Risk of SLE
###end title 24
###begin p 25
###xml 62 69 62 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t003">Table 3</xref>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t004">Table 4</xref>
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 506 512 506 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 521 528 521 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del/del</sup>
###xml 521 528 521 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del/del</sup></italic>
###xml 559 564 559 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/TG</sup>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/TG</sup></italic>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 325 333 <span type="species:ncbi:9606">patients</span>
###xml 479 491 <span type="species:ncbi:9606">participants</span>
We used a Caucasian cohort of age and sex-controlled samples (Table 3) to test the potential association between CD24 polymorphism and risk of SLE. A summary of the CD24 allele and genotype analyses in the SLE patients against controls is shown in Table 4. A significant difference in the allelic frequencies between the SLE patients and the controls was found for P1527 (p = 0.00003), but not for P1056 or P1626. Remarkably, a 2.6-fold decrease in the risk for SLE was found in participants with the P1527TG/del or P1527del/del genotype compared to the P1527TG/TG genotype. These data suggest that the dinucleotide deletion may confer protection against SLE risk.
###end p 25
###begin title 26
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Family-Based Tests for the Association between CD24 Polymorphisms and SLE
###end title 26
###begin p 27
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 439 447 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g002">Figure 2</xref>
We used a total of 187 pedigrees to determine whether the CD24 polymorphisms are associated with SLE risk (with 187 informative nuclear families). A strong association in P1527 was found using TRANSMIT (p = 0.002), but it did not show evidence for transmission disequilibrium for P170, P1056, or P1626 (p > 0.05). Linkage disequilibrium analysis of the four SNPs using the 187 family samples also revealed a low LD between P170 and P1527 (Figure 2B), suggesting that P1527 is independently associated with SLE risk, the same as in MS.
###end p 27
###begin title 28
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Dinucleotide Deletion at P1527 Leads to an Allele-Specific Reduction of CD24 mRNA
###end title 28
###begin p 29
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 321 329 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g004">Figure 4</xref>
###xml 366 368 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 366 368 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 407 412 407 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/TG</sup>
###xml 407 412 407 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/TG</sup></italic>
###xml 434 441 434 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del/del</sup>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del/del</sup></italic>
###xml 600 604 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 675 683 675 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g004">Figure 4</xref>
###xml 766 770 766 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 793 799 793 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 793 799 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 825 833 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g004">Figure 4</xref>
###xml 845 848 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 845 848 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 894 896 894 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 894 896 894 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 1098 1102 1098 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Since P1527 resides in the 3' UTR, its polymorphism may affect the accumulation of its mRNA. To address whether mRNA transcribed from the P1527del allele presents a decrease in its expression levels in vivo, we established an allele-specific real-time PCR (RT-PCR) to measure the allele-specific transcripts. As shown in Figure 4A, the primers designed for the P1527TG allele detected CD24 mRNA in the P1527TG/TG, but not in the P1527del/del individuals, and vice versa. These results demonstrate complete specificity of the primers used. In addition, the conditions used led to the amplification of CD24 cDNA in a strictly dose-dependent fashion over six logs of magnitude (Figure 4B). We therefore used this method to measure the allele-specific expression of two CD24 alleles in eight P1527TG/del individuals. As shown in Figure 4C, the P1527del transcripts were 2.5-fold less than the P1527TG transcripts. Since the two alleles were present in the same cells and therefore were transcribed at the same rate, our data demonstrate that the P1527 variant has a strong impact on mRNA expression of CD24 in vivo, most likely by post-transcriptional mechanisms.
###end p 29
###begin title 30
P1527 Modulates CD24 mRNA Stability
###end title 30
###begin p 31
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b031">31</xref>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 202 210 202 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g005">Figure 5</xref>
###xml 239 254 <span type="species:ncbi:10029">Chinese hamster</span>
P1527 is located in the 3' UTR that modulates mRNA stability [31]. To test if this polymorphism modulates CD24 mRNA stability, we constructed two plasmids (pTracer CMV2-CD24TG and pTracer CMV2-CD24del; Figure 5, top panel) and transfected Chinese hamster ovary (CHO) cells with the two constructs. Starting at 48 hours after transfection, the synthesis of RNA was blocked by actinomycin D, and the half life of mRNA was measured by RT- PCR. The levels of GFP mRNA were used as internal controls for transfection efficiency.
###end p 31
###begin p 32
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 93 95 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 261 269 261 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g005">Figure 5</xref>
###xml 311 313 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 311 313 311 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 541 544 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 616 618 616 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 616 618 616 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 720 724 720 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Prior to actinomycin D treatment, there was significantly higher mRNA expression for the CD24TG cDNA in comparison to the CD24del cDNA. Using the pre-treatment mRNA levels as 100%, we measured the decay kinetics of two mRNA from two different cDNA. As shown in Figure 5 (lower panel), the decay patterns of CD24TG were significantly more gradual than those of CD24del (p < 0.001), and the differences in the rates of decay were significantly different at all time points starting from 0.5 h (all p < 0.001). In particular, mRNA from the CD24del cDNA had a half life of less than 1 h, while that derived from the CD24TG had a half life of more than 4 h. Thus, the dinucleotide deletion at the P1527 position destabilized CD24 mRNA.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b027">27</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b038">38</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b042">42</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b027">27</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b038">38</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b040">40</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b041">41</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b042">42</xref>
It is well established that polymorphisms of immune-related genes modulate host susceptibility to autoimmune diseases, including MS and SLE [27,38-42]. Historically, most studies have focused on polymorphisms that result in the replacement of amino acids [27,38,40]. More recently, substantial information has been accumulated that demonstrates that polymorphisms at the promoter and intron regions can also have a significant impact on susceptibility. These alterations modulate either RNA synthesis (transcription) or splicing [41,42]. Although it is well established that the 3' UTR plays a major role in RNA stability, we are not aware of any study reporting that polymorphism at the 3' UTR modulates susceptibility to autoimmune diseases by changing mRNA stability. Our data presented in this study revealed that a destabilizing dinucleotide deletion in the 3' UTR of the CD24 gene may confer a significant protection against the risk and progression of MS and against the risk of SLE. Our conclusion is based on five lines of evidence.
###end p 34
###begin p 35
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b043">43</xref>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
First, a population study with 275 independent Caucasian MS patients and a comparable size of normal controls revealed that individuals with the deletion in at least one allele had about a 2-fold less relative risk in comparison to those without the deletion. Thus, the CD24 P1527del allele may be a protective genetic susceptibility factor for the onset of MS. This is more remarkable in light of the fact that polymorphisms at sites that were only 100-500 bp apart did not have a significant impact on the risk of MS. The strong association at P1527, but not at the nearby SNPs, suggests that the deletion was causatively related to the reduced MS susceptibility. This interpretation is consistent with the fact that the frequencies of the associated alleles at the two nearby (flanking) loci are very different from that of the protective allele. A recent study showed that the power to detect the association in such loci is diminished even when there is high linkage disequilibrium [43]. This also leads to a reasonable explanation as to why two loci in high LD are not both associated with the disease.
###end p 35
###begin p 36
###xml 151 153 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 151 153 151 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 307 310 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 553 554 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>T</sup></italic>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b027">27</xref>
###xml 902 906 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
Second, using data from two independent cohorts of families, we also established a strong association of the CD24 P1527 polymorphism with MS. The P1527TG allele was preferentially transmitted to affected individuals. This result strongly supports the conclusion from the case-control analysis that the P1527del allele may be a protective genetic susceptibility factor for the onset of MS. Both of these results remain significant after multiple-testing adjustments. Within the Ohio State University (OSU) cohort, our previous data revealed that the P170T allele was preferentially transmitted into affected individuals among multiplex families with two or more MS patients [27]. This result continues to hold with our expanded OSU family set, although not with the MSGG cohort (data not shown). In summary, results from both of population and the family studies confirm our earlier conclusion that the CD24 locus is a major modulator for MS risk.
###end p 36
###begin p 37
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 268 271 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
Third, survival analysis revealed a significant association (even after correcting for multiple tests) of CD24 P1527 with MS disease progression; MS patients with the P1527del allele had a significantly delayed progression. This finding further confirms that the P1527del allele is a protective genetic factor for MS. An interesting issue is whether P1527 is associated with the progression of MS because of its linkage to P170. We consider it very unlikely as our analysis of LD revealed that there is little LD between the two sites despite their close proximity to one another, perhaps due to a recombination hotspot within the CD24 gene. Moreover, P1056, which is closer to P170, is not associated with the progression of MS. We therefore consider it likely that P170 and P1527 are independently associated with the progression of MS. Since P1626 is less than 100 bp away and shows a strong LD with P1527, it remains possible that its association with MS progression may be due to its proximity to P1527. This interpretation is favored as P1626 shows no association with MS risk. Since our analysis has now covered all known CD24 polymorphisms in the exons, it is likely that P1527, rather than other SNPs, is related to protection against autoimmune diseases.
###end p 37
###begin p 38
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b025">25</xref>
Fourth, in addition to MS, which is an organ-specific autoimmune disease, we also observed that the CD24 P1527del allele is preferentially transmitted to unaffected individuals in the SLE family data. It is worth noting that the SLE data should not be regarded as a replication of MS data per se. Rather, our data suggest that the protective effect of the dinucleotide deletion extends to systemic autoimmune diseases. Thus, in addition to its critical role for T-cell proliferation in the central nervous system [25], CD24 may play a role in the development of multiple autoimmune diseases.
###end p 38
###begin p 39
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b044">44</xref>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Based on the observed data pattern and the structure of the family cohorts, we have chosen TRANSMIT soft ware to detect association between CD24 polymorphism and risk of autoimmune diseases to maximize the statistical power. However, we caution that TRANSMIT may have inflated type-I error due to its inferences of missing parental genotypes [44]. Nevertheless, we do not believe the core finding is due to type-I errors, as statistically significant association can also be find with FBAT that deletes data from families without parental information (MS dataset, p = 0.04; SLE data set, p = 0.01).
###end p 39
###begin p 40
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 799 803 799 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Fifth, the dinucleotide deletion reduced steady levels of CD24 mRNA by more than 2-fold. Thus, in heterozygous patients, the mRNA from the alleles with the deletion was only 50% of that of the alleles without the deletion. This is recapitulated in transfection studies. Analysis of RNA decay kinetics revealed that the half life for the CD24 transcript with the dinucleotide deletion was at least 4-fold shorter than that of the wild-type allele. Since CD24 was expressed at high levels among some lineages of hematopoietic cells and in the transfected CHO cells, the reduction in the steady levels may underestimate the reduction in other cell types, such as T cells, in which CD24 is expressed at lower levels and is therefore less likely to saturate the degradation system. The low expression of CD24 in T cells is essential for homeostatic proliferation of T cells, which has been implicated in the development of autoimmune diseases.
###end p 40
###begin p 41
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b029">29</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b045">45</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
In summary, we demonstrated that a dinucleotide deletion at the 3' UTR of the human CD24 gene confers significant protection against the risk and progression of MS and the risk of SLE. These results not only provide insight into the genetic basis of MS and SLE susceptibility, but, perhaps more importantly, to our knowledge, this is the first report that shows how polymorphisms at the 3' UTR modulate susceptibility to autoimmune diseases by regulating RNA stability. Since CD24 is a checkpoint for homeostatic proliferation of T cells [29], which is implicated in other autoimmune diseases [45], it will be of great interest to test the contribution of CD24 to the risk and progression of other autoimmune diseases.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
###xml 3 10 <span type="species:ncbi:9606">patient</span>
MS patient samples.
###end title 43
###begin p 44
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b027">27</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b046">46</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b047">47</xref>
###xml 720 724 720 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 121 133 <span type="species:ncbi:9606">participants</span>
###xml 186 198 <span type="species:ncbi:9606">participants</span>
###xml 245 253 <span type="species:ncbi:9606">Patients</span>
All sample collection and experimentation was approved by the Institutional Review Board, and informed consents from all participants were obtained before sample collection. Some of the participants had been enrolled in the previous study [27]. Patients with definite MS, as diagnosed by K.W.R. and D.J.L. at OSUMultiple Sclerosis Center according to the McDonald criteria [46], were offered the opportunity to participate. The clinical diagnosis of MS type and the EDSS score [47] were determined by three of the authors (K.W.R., D.J.L., and N.G.). The time of disease onset and the time when a walking aid was first prescribed (EDSS 6.0) were determined retrospectively by the analysis of case records without knowing CD24 genotype.
###end p 44
###begin p 45
###xml 313 320 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t001">Table 1</xref>
###xml 67 79 <span type="species:ncbi:9606">participants</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 170 182 <span type="species:ncbi:9606">participants</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 511 523 <span type="species:ncbi:9606">participants</span>
In the case-control study, we selected a consecutive series of 829 participants including 361 MS patients and 468 normal controls. For the case-control analysis based on participants with the same genetic background, we only used 275 independent Caucasian cases and age and gender-matched 443 Caucasian controls (Table 1). All MS patients were recruited at the OSU Medical Center between January 2000 and March 2006 and agreed to participate in this study. All donors gave written informed consent. The control participants were obtained from the American Red Cross (Columbus, Ohio) between September 1999 and January 2006 using leftover peripheral blood samples.
###end p 45
###begin p 46
###xml 102 114 <span type="species:ncbi:9606">participants</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 815 827 <span type="species:ncbi:9606">participants</span>
In the Ohio family study, 101 pedigrees of MS families were used for association analysis. Of the 346 participants from the families, 135 were MS patients and 211 were non-MS relatives. All MS patients and their unaffected family members were recruited at the OSU Medical Center, and all agreed to participate in this study. We interviewed all MS patients for family history of MS. Consenting family members with or without MS provided blood samples as well. In rare cases, when family members were at other locations, samples were obtained by local physicians or nurses and transported or mailed to our center. Ascertainment of the presence or absence of MS among the relatives was by history alone. Relatives who provided blood samples were not subjected to neurological evaluation or an MRI at our center. These participants were selected between October 2001 and May 2005.
###end p 46
###begin p 47
###xml 30 42 <span type="species:ncbi:9606">participants</span>
###xml 173 185 <span type="species:ncbi:9606">participants</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 250 262 <span type="species:ncbi:9606">participants</span>
In the MSGG family study, 321 participants from 49 pedigrees of multiplex MS families were obtained from the MSGG through the University of California San Francisco. Of the participants, 119 were MS patients and 202 were from non-MS relatives. These participants were selected between October 1997 and January 2003.
###end p 47
###begin p 48
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t001">Table 1</xref>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 486 494 <span type="species:ncbi:9606">patients</span>
###xml 551 559 <span type="species:ncbi:9606">patients</span>
###xml 593 601 <span type="species:ncbi:9606">patients</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
Demographics and disease characteristics of the MS patients and controls are summarized in Table 1. The sex ratio and average age of the OSU MS patients were not significantly different from those of normal controls (p = 0.506 in sex; p = 0.970 in age). In all of the OSU MS patients, as well as in each of the familial and sporadic groups, there were no significant correlations among age, age at onset, EDSS, duration of the disease, and clinical course (all p > 0.05). In the OSU MS patients, no information was obtained for the EDSS score in four patients and the clinical course in three patients. The group of patients with some missing phenotypic information was included in our genetic analysis to be detailed below.
###end p 48
###begin p 49
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
The comparison of clinical and demographic features between OSU and MSGG family MS patients did not show any significant differences (p > 0.05). Although there was no significant difference in the ethnicity between the MS patients of the OSU and the MSGG families, the MS patients of the MSGG families were from a number of other countries besides the United States.
###end p 49
###begin title 50
###xml 4 11 <span type="species:ncbi:9606">patient</span>
SLE patient samples.
###end title 50
###begin p 51
###xml 92 99 92 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t003">Table 3</xref>
###xml 602 603 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 620 621 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 184 192 <span type="species:ncbi:9606">Children</span>
###xml 375 387 <span type="species:ncbi:9606">participants</span>
###xml 529 537 <span type="species:ncbi:9606">patients</span>
###xml 651 663 <span type="species:ncbi:9606">participants</span>
###xml 709 721 <span type="species:ncbi:9606">participants</span>
Demographics and disease characteristics of the SLE patients and controls are summarized in Table 3. A total of 264 unrelated SLE patients were consecutively recruited at the Columbus Children's Hospital and Research Institute, OSU, and followed in the Ohio SLE Study. SLE cases for case-control analysis were all independent Caucasians. Healthy race-, sex-, and age-matched participants (270) with no history of autoimmune disease were enrolled from the American Red Cross (Columbus, Ohio). The sex ratio and average age of SLE patients were not significantly different from those of normal controls (p = 0.435 in sex; p = 0.990 in age). The healthy participants were completely independent from the control participants in the MS group. Both case and control samples were collected between 1999 and 2006.
###end p 51
###begin p 52
###xml 412 420 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-st002">Table S2</xref>
###xml 83 91 <span type="species:ncbi:9606">Children</span>
###xml 197 209 <span type="species:ncbi:9606">participants</span>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
A large collection of 187 pedigrees of SLE families was obtained from the Columbus Children's Hospital and Research Institute, OSU, with predominantly one affected offspring per family. Of the 555 participants from the families, 187 were SLE patients and 368 were non-SLE relatives. Samples from both parents were available for 36% of the families, and samples from siblings were also collected where available (Table S2). In the case of single-parent families, samples were always taken from siblings. An extensive questionnaire and interview with a trained physician were completed by unaffected family members to determine the absence of SLE.
###end p 52
###begin p 53
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b030">30</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b048">48</xref>
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030049-t003">Table 3</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b048">48</xref>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 352 364 <span type="species:ncbi:9606">participants</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
The SLE patients were diagnosed according to the classification criteria of the American College of Rheumatology [30,48]. Only those that were diagnosed as definitive SLE were included in the study. The demography and clinical data for the samples were listed in Table 3, using kidney involvement and WHO classifications for disease severity [48]. All participants were Caucasians who gave written informed consent. Approval for human study protocols was obtained from the human subjects review board at OSU and the Institutional Review Board.
###end p 53
###begin title 54
Polymorphism identification.
###end title 54
###begin p 55
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b032">32</xref>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 437 445 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g001">Figure 1</xref>
###xml 798 802 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 875 879 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1054 1063 1036 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030049-sg002">Figure S2</xref>
###xml 1306 1309 1288 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C/T</italic>
###xml 1339 1343 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 1489 1492 1471 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/G</italic>
###xml 1651 1657 1621 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</italic>
###xml 1807 1810 1777 1780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/G</italic>
###xml 2195 2203 2123 2131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g001">Figure 1</xref>
###xml 2239 2255 2167 2183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;C,&#8221; &#8220;A,&#8221; &#8220;del,&#8221;</italic>
###xml 2260 2261 2188 2189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 2355 2370 2283 2298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;T,&#8221; &#8220;G,&#8221; &#8220;TG,&#8221;</italic>
###xml 2374 2377 2302 2305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;G&#8221;</italic>
###xml 2431 2439 2359 2367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030049-g001">Figure 1</xref>
###xml 351 356 <span type="species:ncbi:9606">human</span>
The genomic DNA was isolated from peripheral blood leukocytes (PBL) by using the QIAamp DNA Blood Minikit (Qiagen, ). We searched for polymorphisms in the 3' UTR of exon 2 using PCR and DNA sequencing, and these polymorphisms were further determined by DNA cloning and sequencing. Since several intronless CD24 pseudogenes have been identified in the human genome [32], the functional CD24 locus was selectively amplified by nested PCR (Figure 1). The first PCR amplification (Invitrogen ) was from intron 1 to the end of exon 2 by using a forward primer (5'-CTA AAG AGA ATG ACC TTG GTG GGT TGA G-3') and a reverse primer (5'-CAC AGT AGC TTC AAA ACT GTT CGA-3'). The PCR conditions were as follows: 94 degreesC for 30 s, 55 degreesC for 30 s, and 68 degreesC for 2 min for 20 cycles. The predicted CD24 PCR fragment was 2,017 bp long. The identity of the PCR products to the CD24 gene sequence on Chromosome 6, but not the putative Chromosome Y locus sequence as well as the SNP in the region was confirmed by cloning and sequencing of the PCR products (Figure S2). The second PCR amplification (Promega, ) was based on each polymorphic site using the primers as follows: a forward primer (5'-CTA AAG AGA ATG ACC TTG GTG GGT TGA G-3') and a reverse primer (5'-GGA TTG GGT TTA GAA GAT GGG GAA A-3') for 170 C/T polymorphism (P170) from the CD24 translation start site, a forward primer (5'-GGC ATT TCC TAT CAC CTG TTT-3') and a reverse primer (5'-AAT CTA CCC CCA GAT CCA AGC A-3') for 1056 A/G polymorphism (P1056), a forward primer (5'-GCA ATT TTG CCT TCA AAA CAG-3') and a reverse primer (5'-TTT AGG CTT AGG ACC AGG TTC-3') for 1527approximately1528 TG/del polymorphism (P1527), and a forward primer (5'-CAA CTA TGG ATC AGA ATA GCA ACA AT-3') and a reverse primer (5'-GGAACATCTAAGCATCAGTGTGTG-3') for 1626 A/G polymorphism (P1626). The PCR conditions were as follows: 94 degreesC for 30 s, 55 degreesC for 30 s, and 72 degreesC for 30 s, for 35 cycles. The PCR products were digested overnight with BstXI (50 degreesC) for P170, BstUI (60 degreesC) for P1056, BsrI (65 degreesC) for P1527, and MfeI (37 degreesC) for P1626 (New England Biolabs, ) and then electrophoresed on 3.0% agarose gels (Figure 1). The genotypes were designated as "C," "A," "del," or "A" when the restriction sites of BstXI, BstUI, BsrI, and MfeI were respectively absent, and as "T," "G," "TG," or "G" when each restriction site was respectively present (Figure 1). The validity of the PCR-RFLP analysis was confirmed by direct sequencing of several PCR samples with each genotype.
###end p 55
###begin title 56
Molecular cloning and plasmid construction.
###end title 56
###begin p 57
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 89 95 89 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 555 557 555 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 555 557 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 579 582 579 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 579 582 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
CD24 cDNA was amplified from the peripheral blood leukocyte of individuals with the P1527TG/del genotype by RT-PCR (Invitrogen). The following primers were used: a forward primer (5'-ATG GGC AGA GCA ATG GTG-3') and a reverse primer (5'-CAC AGT AGC TTC AAA ACT GTT CGA-3'). The PCR products (1,842 bp) were cloned into the TOPO-pCDNA2.0 vector (Invitrogen), which was digested with KpnI/NotI, and then the PCR products with the additional KpnI/NotI site were cloned into the pTracer CMV2 vector (Invitrogen), thus generating two plasmids, pTracer CMV2-CD24TG and pTracer CMV2-CD24del . The sequence of two CD24 cDNA inserts was confirmed by DNA sequencing. To exclude potential confounding factors, we selected the same sequence at the P170, P1056, and P1626 sites between the two plasmids.
###end p 57
###begin title 58
Cell culture and DNA transfection.
###end title 58
###begin p 59
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
To test the expression efficiency of the CD24 alleles, we transfected varying concentrations of plasmids into CHO cells using FuGENE 6 (Roche, ). For the RNA stability experiment, 48 h after transfection, CHO cells were treated with actinomycin D (5 mug/ml) (Sigma, St. Louis, Mo.) for 0.5, 1, 2, 3, and 4 h. Untreated cells were used as control at the 0 h time point.
###end p 59
###begin title 60
RT-PCR.
###end title 60
###begin p 61
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
We isolated total RNA from 1 x 106 transfected CHO cells using a commercially available kit (Qiagen). We exposed RNA samples to DNase digestion before cDNA synthesis. For gene-specific PCR, 1 mul of first-strand cDNA product was amplified with platinum Taq polymerase (Invitrogen) according to the manufacturer's instructions. We designed primers specific for CD24 (forward: 5'-CCC ACG CAG ATT TAT TCC AGT-3', reverse: 5'-TGG TGG TGG CAT TAG TTG GAT-3') and for GFP (forward: 5'-GGT GAT GTT AAT GGG CAC AA-3', reverse: 5'-TAG TGA CAA GTG TTG GCC ATG-3') and performed a 30-cycle, three-step PCR (denaturation at 95 degreesC for 30 s, annealing at 55 degreesC for 30 s, extension at 68 degreesC for 30 s) with an initial temperature of 95 degreesC for 10 min.
###end p 61
###begin p 62
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 337 338 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>t</sub></italic>
###xml 526 539 526 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
An ABI Prism 7900-HT sequence system (Applied Biosystems, ) with the QuantiTect SYBR Green PCR kit (Qiagen) was used in accordance with the manufacturer's instructions. A standard curve was created in each experiment using serial dilutions of positive template (plasmid). The relative amount of CD24 mRNA was calculated by plotting the Ct (cycle number) against the standard curve and comparing this to GFP as an endogenous control. The average relative expression for each group was determined using the comparative method (2-DeltaDeltaCt). We used samples either without a template or with a template where the reverse-transcription step had been omitted as controls for unspecific contamination and amplification of plasmid DNA, respectively.
###end p 62
###begin title 63
Allele-specific mRNA expression assay.
###end title 63
###begin p 64
###xml 82 88 82 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 468 474 468 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 468 474 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 578 580 578 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 578 580 578 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 635 637 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 635 637 635 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 705 707 705 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 705 707 705 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 770 773 770 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 770 773 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 831 834 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 831 834 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 905 908 905 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 905 908 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 1215 1217 1215 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 1215 1217 1215 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 1238 1241 1238 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 1238 1241 1238 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Genomic DNA from eight OSU MS patients was initially genotyped to identify a P1527TG/del heterozygote and the corresponding cDNA samples were initially analyzed by using a TaqMan gene expression assay. Sample cDNAs were amplified in a model 7900-HT sequence system (Applied Biosystems) using the forward and reverse primers and a FAM dye-labeled TaqMan MGB probe with a TaqMan PCR reagent kit (Applied Biosystems). The sequence of primers and the probes for CD24 P1527TG/del, which were designed by Applied Biosystems, were 5'-AGAAGGCAAAATGTAAAGGAGTCAAACT-3' for a forward P1527TG primer, 5'-FAM-TTCCAGTCTTCACTTCCC-TAMRA-3' for a P1527TG probe, 5'-GTTGCTATTCTGATCCATAGTTGTTTTTTAAAGA-3' for a reverse P1527TG primer, 5'-AGAAGGCAAAATGTAAAGGAGTCAAACT-3' for a forward P1527del primer, 5'-FAM-AAGTGAAGACGAAGCTAATTT-TAMRA-3' for a P1527del probe , and 5'-TTCTAAATGTTGCTATTCTGATCCATAGTTGT-3' for a reverse P1527del primer. Quantitative PCR was carried out in 96-well optical reaction plates using a cDNA equivalent of 50 ng of total RNA for each sample in a volume of 50 ml using the TaqMan Universal PCR Master Mix (Applied Biosystems) according to the manufacturer's instructions. The mixed plasmid of pTracer CMV2-CD24TGand pTracer CMV2-CD24del in the same concentrations was used as a template for making the standard curve. The known concentrations of the serially diluted CD24 plasmid mix were employed as a standard for the quantification of the sample cDNAs. Each sample was assayed in triplicate and the intra-assay coefficient of variation was less than 1%. Experiments were repeated three times.
###end p 64
###begin title 65
Statistical analysis.
###end title 65
###begin p 66
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 378 379 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 526 527 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 31 39 <span type="species:ncbi:9606">Patients</span>
Case-control population study. Patients and normal controls were examined for any significant differences in their genotype (allele) distributions in each of the CD24 polymorphisms at the population level. First, the Hardy-Weinberg equilibrium assumption was checked for each polymorphism for the cases and controls separately. After such data quality analyses, we performed chi2 tests for each polymorphism by comparing the distribution of the genotypes (alleles) of the cases to that of the normal controls. We computed the p-values of the test statistics using Monte Carlo simulations to avoid the assumptions of asymptotic distributions that may not be valid for small counts. Then, using the counts of one of the genotypes (allele) as a reference, the odds ratios for the remaining genotype (allele) variants were computed. The associated 95% confidence intervals for the odds ratios were obtained through bootstrap resampling methods. All Monte Carlo simulations were performed with 100,000 iterations.
###end p 66
###begin title 67
Analysis using family data.
###end title 67
###begin p 68
###xml 300 308 <span type="species:ncbi:9606">Children</span>
Since case control studies are, in general, sensitive to population stratification, which may render the interpretation of results less than satisfactory, we also considered transmission disequilibrium tests using family data from three cohorts; the OSU MS samples, the MSGG MS samples, and Columbus Children's Hospital SLE samples. We checked for Mendelian inconsistencies and obligatory double recombination, using Merlin to test the typing errors.
###end p 68
###begin p 69
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b034">34</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b035">35</xref>
The numbers of families with transmissions to affected offspring are: OSU MS, 87; MSGG, 63; and SLE cohort, 189. In these analyses, we hoped to confirm any significant association uncovered in the case control studies to further strengthen the results. Each polymorphism was examined for transmission disequilibrium using the TRANSMIT software [34,35] to uncover any association between the polymorphism and MS or SLE. TRANSMIT can deal with data from general pedigrees, the same type of data collected in our family studies.
###end p 69
###begin title 70
Linkage disequilibrium.
###end title 70
###begin p 71
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b049">49</xref>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 216 217 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
Analysis of the four SNPs was carried out using Haploview [49] software to study the LD pattern in the CD24 gene using the Caucasian family data from the three independent cohorts. Specifically, pairwise LD measure r2 was calculated for each of the six pairs of SNPs, and their results were displayed in a tilted matrix. While all families' data were used for phase (haplotype) information, only unrelated individuals were used for calculating the LD.
###end p 71
###begin title 72
Survival analysis.
###end title 72
###begin p 73
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030049-b050">50</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 179 186 <span type="species:ncbi:9606">patient</span>
For each SNP, we estimated the Kaplan-Meier survival curve for patients with each of the genotypes associated with the polymorphism. We calculated the observed survival time of a patient as the time from the first day of symptoms to reaching EDSS 6.0 (in years) or to the day of the last follow-up visit if EDSS 6.0 had not been reached. In the latter situation, the recorded survival time was treated as a censored observation. Association between the estimated survival curves and the underlying genotypes were then assessed using a log-rank test [50].
###end p 73
###begin title 74
Analysis of expression data.
###end title 74
###begin p 75
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 637 639 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 633 639 633 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24<sup>TG</sup></italic>
###xml 662 665 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 658 665 658 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24<sup>del</sup></italic>
A paired t-test was used to assess the effect of the dinucleotide deletion of P1527 on the allele-specific reduction of CD24 mRNA. Due to the small sample size (eight individuals) used, the p-value was calculated based on 1,000,000 Monte Carlo simulations without making the normality assumption of the underlying population. For the mRNA stability data, an analysis of variance was performed to test the hypothesis that P1527 modulates CD24 mRNA stability. The dependency through time was taken into account by modeling the covariance using an autoregressive process. To test our hypothesis, we contrasted the decay patterns of the CD24TG with those of the CD24del. In addition, we tested their difference at each individual time point.
###end p 75
###begin title 76
Supporting Information
###end title 76
###begin title 77
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
CD24 Sequence Based on Celera Database
###end title 77
###begin p 78
(31 KB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin title 80
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 19 24 <span type="species:ncbi:9606">Human</span>
Comparison between Human CD24 Genomic DNA Sequence, Based on Sequences of Five Clones of PCR Products from Each of Eight Individuals (Four Males and Four Females, a Total of 40 Clones), and That of NC_000024.8 from the NCBI Database
###end title 80
###begin p 81
(45 KB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin title 83
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCD24</italic>
###xml 70 82 <span type="species:ncbi:9606">Participants</span>
Distribution of hCD24 Genotype Frequencies in Female and Male Control Participants is Inconsistent with Significant Contribution of Y-Chromosomal Genes
###end title 83
###begin p 84
(62 KB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin title 86
Characterization and Composition of Three Family Groups
###end title 86
###begin p 87
(52 KB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin title 89
Accession Numbers
###end title 89
###begin p 90
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
The National Center for Biotechnology Information (NCBI) () accession number for the putative CD24 sequence on Chromosome Y is NC_000024.8.
###end p 90
###begin p 91
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
The NCBI accession numbers for the CD24 SNPs discussed in this paper are P1056 A/G, rs1058818; P1527 TG/del, rs3838646; and P1626 A/G, rs1058881.
###end p 91
###begin p 92
We thank Drs. Hauser and Oksenberg for the MSGG samples and Lynde Shaw for secretarial assistance. Part of the study was carried out when all of the authors were at the Ohio State University.
###end p 92
###begin title 93
Abbreviations
###end title 93
###begin p 94
###xml 0 15 <span type="species:ncbi:10029">Chinese hamster</span>
Chinese hamster ovary
###end p 94
###begin p 95
expanded disability status scale
###end p 95
###begin p 96
linkage disequilibrium
###end p 96
###begin p 97
multiple sclerosis
###end p 97
###begin p 98
Multiple Sclerosis Genetics Group
###end p 98
###begin p 99
Ohio State University
###end p 99
###begin p 100
restriction length fragment polymorphism
###end p 100
###begin p 101
real-time PCR
###end p 101
###begin p 102
systemic lupus erythematosus
###end p 102
###begin p 103
single-nucleotide polymorphism
###end p 103
###begin title 104
References
###end title 104
###begin article-title 105
A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group
###end article-title 105
###begin article-title 106
Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group
###end article-title 106
###begin article-title 107
Genetics of multiple sclerosis
###end article-title 107
###begin article-title 108
Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis
###end article-title 108
###begin article-title 109
Multiple sclerosis
###end article-title 109
###begin article-title 110
Environmental risk factors in multiple sclerosis aetiology
###end article-title 110
###begin article-title 111
Parent-of-origin effect in multiple sclerosis: Observations in half-siblings
###end article-title 111
###begin article-title 112
Twin concordance and sibling recurrence rates in multiple sclerosis
###end article-title 112
###begin article-title 113
Modelling multiple sclerosis
###end article-title 113
###begin article-title 114
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group
###end article-title 114
###begin article-title 115
A genome screen in multiple sclerosis reveals susceptibility loci on Chromosome 6p21 and 17q22
###end article-title 115
###begin article-title 116
###xml 49 54 <span type="species:ncbi:9606">human</span>
A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families
###end article-title 116
###begin article-title 117
###xml 15 20 <span type="species:ncbi:9606">human</span>
Genome scan of human systemic lupus erythematosus: evidence for linkage on Chromosome 1q in African-American pedigrees
###end article-title 117
###begin article-title 118
###xml 20 25 <span type="species:ncbi:9606">human</span>
Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families
###end article-title 118
###begin article-title 119
###xml 15 20 <span type="species:ncbi:9606">human</span>
Genome scan of human systemic lupus erythematosus by regression modeling: Evidence of linkage and epistasis at 4p16-15.2
###end article-title 119
###begin article-title 120
###xml 27 32 <span type="species:ncbi:9606">human</span>
A susceptibility locus for human systemic lupus erythematosus (hSLE1) on Chromosome 2q
###end article-title 120
###begin article-title 121
###xml 59 64 <span type="species:ncbi:9606">human</span>
Evidence for linkage of a candidate Chromosome 1 region to human systemic lupus erythematosus
###end article-title 121
###begin article-title 122
Delineating the genetic basis of systemic lupus erythematosus
###end article-title 122
###begin article-title 123
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Heat-stable antigen/CD24 on mouse T lymphocytes: Evidence for a costimulatory function
###end article-title 123
###begin article-title 124
Homotypic interaction of the heat-stable antigen is not responsible for its co-stimulatory activity for T cell clonal expansion
###end article-title 124
###begin article-title 125
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth
###end article-title 125
###begin article-title 126
Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages
###end article-title 126
###begin article-title 127
Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells
###end article-title 127
###begin article-title 128
The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis
###end article-title 128
###begin article-title 129
CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis
###end article-title 129
###begin article-title 130
The small cell lung cancer antigen cluster-4 and the leukocyte antigen CD24 are allelic isoforms of the same gene (CD24) on Chromosome band 6q21
###end article-title 130
###begin article-title 131
CD24 is a genetic modifier for risk and progression of multiple sclerosis
###end article-title 131
###begin article-title 132
Massive and destructive T cell response to homeostatic cue in CD24-deficient lymphopenic hosts
###end article-title 132
###begin article-title 133
CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host
###end article-title 133
###begin article-title 134
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
###end article-title 134
###begin article-title 135
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Regulation of the stability of the heat-stable antigen mRNA by interplay between two novel cis-elements in the 3' untranslated region
###end article-title 135
###begin article-title 136
Mapping of CD24 and homologous sequences to multiple chromosomal loci
###end article-title 136
###begin article-title 137
Merlin-rapid analysis of dense genetic maps using sparse gene flow trees
###end article-title 137
###begin article-title 138
A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission
###end article-title 138
###begin article-title 139
Transmission/disequilibrium tests for extended marker haplotypes
###end article-title 139
###begin article-title 140
CD24 Ala/Val polymorphism and multiple sclerosis
###end article-title 140
###begin article-title 141
CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population
###end article-title 141
###begin article-title 142
A molecular basis for MHC class II-associated autoimmunity
###end article-title 142
###begin article-title 143
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells
###end article-title 143
###begin article-title 144
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes
###end article-title 144
###begin article-title 145
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
###end article-title 145
###begin article-title 146
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis
###end article-title 146
###begin article-title 147
Genetic analysis of complex diseases
###end article-title 147
###begin article-title 148
Accounting for linkage in family-based tests of association with missing parental genotypes
###end article-title 148
###begin article-title 149
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity
###end article-title 149
###begin article-title 150
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis
###end article-title 150
###begin article-title 151
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
###end article-title 151
###begin article-title 152
The 1982 revised criteria for the classification of systemic lupus erythematosus
###end article-title 152
###begin article-title 153
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 153
###begin title 154
Figures and Tables
###end title 154
###begin title 155
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Diagram of the CD24 Gene and Genotyping of Four Polymorphic Sites by PCR-RFLP
###end title 155
###begin p 156
The upper panel shows the relative position of the 3'-UTR (gray box) and the two codon regions (white boxes). Intron 1 is represented as a separate line; however, the large intron 1 is not fully represented in the figure. The relative position of each polymorphism found in the study is shown by a downward arrow. The position of the nested-PCR primers is also shown. Lower panel shows genotyping by PCR-RFLP analysis using BstX I, BstU I, Bsr I, and Mfe I restriction enzymes for P170, P1056, P1527, and P1626, respectively. The genotype of each pattern is indicated at the bottom of each lane. M: molecular size marker (lane 1, 6, 11, and 16). Numbers on the left side are the size of a standard DNA marker (bp). N: negative control (lane 5, 10, 15, and 20).
###end p 156
###begin title 157
LD Analysis of Four Polymorphic Sites in the CD24 Gene
###end title 157
###begin p 158
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The data from two cohorts of families are presented. Pairwise LD measure r2 in the display was calculated for each of the six pairs of SNPs using data from three cohorts of families and the results are displayed in a tilted matrix.
###end p 158
###begin p 159
(A) Data from the OSU and MSGG families.
###end p 159
###begin p 160
###xml 54 62 <span type="species:ncbi:9606">Children</span>
(B) Data from the SLE families' samples from Columbus Children's Hospital. Complete LD was observed between 1056 and 1527/1626 in the SLE family sample cohort between 1056 and 1527.
###end p 160
###begin title 161
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 76 84 <span type="species:ncbi:9606">Patients</span>
Kaplan-Meier Curves for Overall Survival by CD24 Polymorphisms among OSU MS Patients
###end title 161
###begin p 162
###xml 67 75 <span type="species:ncbi:9606">patients</span>
(A) No significant difference was found in the survival rate among patients with the P1056 genotype.
###end p 162
###begin p 163
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 129 131 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 4 12 <span type="species:ncbi:9606">Patients</span>
(B) Patients carrying the variant P1527del allele had a higher survival rate than those who had two copies of the wild-type P1527TG allele.
###end p 163
###begin p 164
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>AA</sup></italic>
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AG</sup>
###xml 90 92 90 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>AG</sup></italic>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</sup>
###xml 101 103 101 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>GG</sup></italic>
###xml 4 12 <span type="species:ncbi:9606">Patients</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
(C) Patients with the P1626AA genotype had a lower survival rate than those with the P1626AG or P1626GG genotype. Numbers in parentheses are the size of samples for MS patients. Forty-five percent of the MS patients have reached EDSS 6.0.
###end p 164
###begin title 165
###xml 36 42 36 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
Allele-Specific Transcripts in P1527TG/del Heterozygous Individuals
###end title 165
###begin p 166
###xml 77 83 77 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Total RNA was isolated from the blood of eight OSU MS patients with the P1527TG/del heterozygous genotype. The allele mRNA expression of CD24 was analyzed using TaqMan RT-PCR.
###end p 166
###begin p 167
###xml 72 74 72 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</italic>
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 200 207 <span type="species:ncbi:9606">patient</span>
(A) Specificity of the primers. DNA from patients homozygous for either TG or del at the P1527 was amplified with allele-specific primers. Note that no products were detected when the primers and the patient genotypes were mismatched.
###end p 167
###begin p 168
(B) Standard curve of the allele-specific amplification. The known copies of plasmid cDNA were used as templates.
###end p 168
###begin p 169
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 82 88 82 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG/del</sup>
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG/del</sup></italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 304 306 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 316 317 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
(C) Quantification of allele-specific CD24 transcripts. Total RNA from eight P1527TG/del patients was amplified with allele-specific primers. The copy numbers were calculated based on the standard curves. A significant difference in the mRNA expression of CD24 was observed between the P1527del and P1527TG alleles (p < 0.0001). Data shown have been repeated twice.
###end p 169
###begin title 170
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
Dinucleotide Deletion at P1527 Destabilizes CD24 mRNA
###end title 170
###begin p 171
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 211 214 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 679 681 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</sup>
###xml 679 681 679 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TG</sup></italic>
###xml 690 693 690 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 706 707 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The top panel depicts vector constructs used in the analysis. The CD24 cDNA and the GFP-Zeocin have a different promoter and poly-A site cassette, respectively. Vectors with different haplotypes, CD24TG and CD24del, were used to transfect CHO cells. The lower panel shows the kinetics of mRNA degradation. The amount of CD24 mRNA was quantified using RT-PCR. Actinomycin D treatment was administered at 48 h after transfection, and the total RNA was extracted at 0, 0.5, 1, 2, 3, and 4h after actinocmycin D treatment. The relative amount of CD24 mRNA was calculated as the percentage of untreated mRNA. A significant difference in CD24 mRNA degradation was observed between CD24TG and CD24del haplotypes (p < 0.0001, Fisher's PLSD test). Error bars represent the standard deviation of mean. Data shown have been repeated twice.
###end p 171
###begin p 172
###xml 22 30 <span type="species:ncbi:9606">Patients</span>
Characteristics of MS Patients and Controls
###end p 172
###begin p 173
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 37 49 <span type="species:ncbi:9606">Participants</span>
CD24 Genotype Frequencies for All MS Participants and Controls
###end p 173
###begin p 174
###xml 23 31 <span type="species:ncbi:9606">Patients</span>
Characteristics of SLE Patients and Controls
###end p 174
###begin p 175
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 38 50 <span type="species:ncbi:9606">Participants</span>
CD24 Genotype Frequencies for All SLE Participants and Controls
###end p 175
###begin p 176
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. YL, PZ, and XZ have equity interest in OncoImmune.
###end p 176
###begin p 177
A previous version of this article appeared as an Early Online Release on February 21, 2007 (doi:).
###end p 177
###begin p 178
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. PZ and YL conceived and designed the experiments. LW, JQL, RHL, QZ, TW, and XZ performed the experiments. LW, SL, ZL, and YL analyzed the data. SL, KWR, NG, JL, DJB, BHR, LAH, YW, DJL, GC, and CYY contributed reagents/materials/analysis tools. LW, SL, KWR, PZ, and YL wrote the paper.
###end p 178
###begin p 179
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This study is supported by grants from the US National Institutes of Heath and by a Biomedical Research Technology Transfer Fund from the state of Ohio.
###end p 179

